Transcriptome interrogation of human myometrium identifies differentially expressed sense-antisense pairs of protein-coding and long non-coding RNA genes in spontaneous labor at term

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 27, Issue 14, 2014, Pages 1397-1408

  Romero, Roberto ^a,b,c   Tarca, Adi L ^a,d   Chaemsaithong, Piya ^a   Miranda, Jezid ^a   Chaiworapongsa, Tinnakorn ^a,d   Jia, Hui ^d   Hassan, Sonia S ^a,d   Kalita, Cynthia A ^d   Cai, Juan ^d   Yeo, Lami ^a,d   Lipovich, Leonard ^d  

^a WAYNE STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

^d WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Genomics; LncRNA; Parturition; Pregnancy; Preterm birth

Indexed keywords

COMPLEMENTARY RNA; LONG UNTRANSLATED RNA; SUPPRESSOR OF CYTOKINE SIGNALING 2; TRANSCRIPTOME; MESSENGER RNA;

ADULT; ARTICLE; CESAREAN SECTION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GENE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE LOCUS; GENE STRUCTURE; GENETIC ASSOCIATION; GENETIC CONSERVATION; GENETIC CORRELATION; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; LABOR; LMCD1 GENE; MICROARRAY ANALYSIS; MICROARRAY KIT; MYOMETRIUM; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA GENE; RNA SPLICING; SOCS2 GENE; UPREGULATION; YOUNG ADULT; DNA MICROARRAY; GENETICS; METABOLISM; NEWBORN; OPEN READING FRAME; PREGNANCY; TERM BIRTH;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; GENE EXPRESSION PROFILING; HUMANS; INFANT, NEWBORN; LABOR, OBSTETRIC; MYOMETRIUM; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OPEN READING FRAMES; PREGNANCY; RNA, ANTISENSE; RNA, LONG NONCODING; RNA, MESSENGER; TERM BIRTH; TRANSCRIPTOME; YOUNG ADULT;

EID: 84906268229     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2013.860963     Document Type: Article

References (185)

1. Zhang J, Troendle J, Reddy UM, et al. Contemporary cesarean delivery practice in the United States. Am J Obstet Gynecol 2010; 203:326.e1-10.
2. Boyle A, Reddy UM, Landy HJ, et al. Primary cesarean delivery in the United States. Obstet Gynecol 2013;122:33-40.
3. Brennan DJ, Robson MS, Murphy M, O'Herlihy C. Comparative analysis of international cesarean delivery rates using 10-group classification identifies significant variation in spontaneous labor. Am J Obstet Gynecol 2009;201:308.e301-8.
4. Gifford DS, Morton SC, Fiske M, et al. Lack of progress in labor as a reason for cesarean. Obstet Gynecol 2000;95:589-95.
5. Getahun D, Strickland D, Lawrence JM, et al. Racial and ethnic disparities in the trends in primary cesarean delivery based on indications. Am J Obstet Gynecol 2009;201:422.e421-7.
6. Barber EL, Lundsberg LS, Belanger K, et al. Indications contributing to the increasing cesarean delivery rate. Obstet Gynecol 2011;118:29-38.
7. Branch DW, Silver RM. Managing the primary cesarean delivery rate. Clin Obstet Gynecol 2012;55:946-60.
8. Hamilton BE, Martin JA, Ventura SJ. Births: preliminary data for 2012. National Vital Stat Reports 2013;62:1-33.
9. Simon AE, Uddin SG. National trends in primary cesarean delivery, labor attempts, and labor success, 1990-2010. Am J Obstet Gynecol 2013;209:554.e1-8.
10. World Health Organization. Born too soon: the global action report in preterm birth. WHO Library Cataloguing-in-Publication: World Health Organization; 2012.
11. Beck S, Wojdyla D, Say L, et al. The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity. Bull World Health Organ 2010;88:31-8.
12. Goldenberg RL, McClure EM. The epidemiology of preterm birth. In: Berguella V, ed. Preterm birth: prevention & management. Oxford: Willey-Blackwell; 2010:22-38.
13. Blencowe H, Cousens S, Oestergaard MZ, et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet 2012;379:2162-72.
14. Hamilton BE, Hoyert DL, Martin JA, et al. Annual summary of vital statistics: 2010-2011. Pediatrics 2013;131:548-58.
15. PeriStats [online database]. White Plains (NY): March of Dimes; 2006. Available from: http://www.marchofdimes.com/peristats/[last accessed Dec 2013].
16. Wahlestedt C. Natural antisense and noncoding RNA transcripts as potential drug targets. Drug Discov Today 2006;11:503-8.
17. Wahlestedt C. Targeting long non-coding RNA to therapeutically upregulate gene expression. Nat Rev Drug Discov 2013;12:433-46.
18. Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998;4:844-7.
19. Hedenfalk I, Duggan D, Chen Y, et al. Gene-expression profiles in hereditary breast cancer. N Engl J Med 2001;344:539-48.
20. Tubbs RR, Hicks DG, Cook J, et al. Fluorescence in situ hybridization (FISH) as primary methodology for the assessment of HER2 Status in adenocarcinoma of the breast: a single institution experience. Diagn Mol Pathol 2007;16:207-10.
21. Inaki K, Hillmer AM, Ukil L, et al. Transcriptional consequences of genomic structural aberrations in breast cancer. Genome Res 2011; 21:676-87.
22. Meyerson M, Gabriel S, Getz G. Advances in understanding cancer genomes through second-generation sequencing. Nat Rev Genet 2010;11:685-96.
23. Hondow HL, Fox SB, Mitchell G, et al. A high-throughput protocol for mutation scanning of the BRCA1 and BRCA2 genes. BMC Cancer 2011;11:265.
24. Navin N, Kendall J, Troge J, et al. Tumour evolution inferred by single-cell sequencing. Nature 2011;472:90-4.
25. Previati M, Manfrini M, Galasso M, et al. Next generation analysis of breast cancer genomes for precision medicine. Cancer Lett 2013; 339:1-7.
26. Mudvari P, Ohshiro K, Nair V, et al. Genomic insights into triplenegative and HER2-positive breast cancers using isogenic model systems. PLoS One 2013;8:e74993.
27. Donahue HJ, Genetos DC. Genomic approaches in breast cancer research. Brief Funct Genomics 2013;12:391-6.
28. Kaur H, Mao S, Shah S, et al. Next-generation sequencing: a powerful tool for the discovery of molecular markers in breast ductal carcinoma in situ. Expert Rev Mol Diagn 2013;13: 151-65.
29. Kosir MA, Jia H, Ju D, Lipovich L. Challenging paradigms: long non-coding RNAs in breast ductal carcinoma in situ (DCIS). Front Genet 2013;4:50.
30. Auffray C, Chen Z, Hood L. Systems medicine: the future of medical genomics and healthcare. Genome Med 2009;1:2.
31. Stewart JJ, White JT, Yan X, et al. Proteins associated with Cisplatin resistance in ovarian cancer cells identified by quantitative proteomic technology and integrated with mRNA expression levels. Mol Cell Proteomics 2006;5:433-43.
32. Lin B, White JT, Lu W, et al. Evidence for the presence of diseaseperturbed networks in prostate cancer cells by genomic and proteomic analyses: a systems approach to disease. Cancer Res 2005;65:3081-91.
33. Pascal LE, Vencio RZ, Page LS, et al. Gene expression relationship between prostate cancer cells of Gleason 3, 4 and normal epithelial cells as revealed by cell type-specific transcriptomes. BMC Cancer 2009;9:452.
34. Li R, Guo Y, Han BM, et al. Proteomics cataloging analysis of human expressed prostatic secretions reveals rich source of biomarker candidates. Proteomics Clin Appl 2008;2:543-55.
35. True L, Coleman I, Hawley S, et al. A molecular correlate to the Gleason grading system for prostate adenocarcinoma. Proc Natl Acad Sci USA 2006;103:10991-6.
36. Sung J, Kim PJ, Ma S, et al. Multi-study integration of brain cancer transcriptomes reveals organ-level molecular signatures. PLoS Comput Biol 2013;9:e1003148.
37. Li XJ, Hayward C, Fong PY, et al. A blood-based proteomic classifier for the molecular characterization of pulmonary nodules. Sci Transl Med 2013;5:207ra142.
38. Horikawa Y, Oda N, Cox NJ, et al. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet 2000;26:163-75.
39. Simon R, Roychowdhury S. Implementing personalized cancer genomics in clinical trials. Nat Rev Drug Discov 2013;12: 358-69.
40. McKillop AM, Flatt PR. Emerging applications of metabolomic and genomic profiling in diabetic clinical medicine. Diabetes Care 2011;34:2624-30.
41. Tromp G, Kuivaniemi H, Romero R, et al. Genome-wide expression profiling of fetal membranes reveals a deficient expression of proteinase inhibitor 3 in premature rupture of membranes. Am J Obstet Gynecol 2004;191:1331-8.
42. Romero R, Espinoza J, Gotsch F, et al. The use of high-dimensional biology (genomics, transcriptomics, proteomics, and metabolomics) to understand the preterm parturition syndrome. BJOG 2006; 113:118-35.
43. Khoury MJ, Romero R. The integration of genomics into obstetrics and gynecology: a HuGE challenge. Am J Obstet Gynecol 2006; 195:1503-5.
44. Romero R, Tromp G. High-dimensional biology in obstetrics and gynecology: functional genomics in microarray studies. Am J Obstet Gynecol 2006;195:360-3.
45. Romero R, Mazaki-Tovi S, Vaisbuch E, et al. Metabolomics in premature labor: a novel approach to identify patients at risk for preterm delivery. J Matern Fetal Neonatal Med 2010;23: 1344-59.
46. Toft JH, Lian IA, Tarca AL, et al. Whole-genome microarray and targeted analysis of angiogenesis-regulating gene expression (ENG, FLT1, VEGF, PlGF) in placentas from pre-eclamptic and small-forgestational-age pregnancies. J Matern Fetal Neonatal Med 2008;21: 267-73.
47. Rajakumar A, Chu T, Handley DE, et al. Maternal gene expression profiling during pregnancy and preeclampsia in human peripheral blood mononuclear cells. Placenta 2011;32:70-8.
48. Vaiman D, Calicchio R, Miralles F. Landscape of transcriptional deregulations in the preeclamptic placenta. PLoS One 2013;8: e65498.
49. Varkonyi T, Nagy B, Fule T, et al. Microarray profiling reveals that placental transcriptomes of early-onset HELLP syndrome and preeclampsia are similar. Placenta 2011;32:S21-9.
50. Chaiworapongsa T, Romero R, Whitten A, et al. Differences and similarities in the transcriptional profile of peripheral whole blood in early and late-onset preeclampsia: insights into the molecular basis of the phenotype of preeclampsiaa. J Perinat Med 2013;41: 485-504.
51. Madsen-Bouterse SA, Romero R, Tarca AL, et al. The transcriptome of the fetal inflammatory response syndrome. Am J Reprod Immunol 2010;63:73-92.
52. Lee J, Romero R, Chaiworapongsa T, et al. Characterization of the fetal blood transcriptome and proteome in maternal anti-fetal rejection: evidence of a distinct and novel type of human fetal systemic inflammatory response. Am J Reprod Immunol 2013;70: 265-84.
53. Aguan K, Carvajal JA, Thompson LP, Weiner CP. Application of a functional genomics approach to identify differentially expressed genes in human myometrium during pregnancy and labour. Mol Hum Reprod 2000;6:1141-5.
54. Chan EC, Fraser S, Yin S, et al. Human myometrial genes are differentially expressed in labor: a suppression subtractive hybridization study. J Clin Endocrinol Metab 2002;87:2435-41.
55. Romero R, Kuivaniemi H, Tromp G. Functional genomics and proteomics in term and preterm parturition. J Clin Endocrinol Metab 2002;87:2431-4.
56. Esplin MS, Peltier MR, Hamblin S, et al. Monocyte chemotactic protein-1 expression is increased in human gestational tissues during term and preterm labor. Placenta 2005;26:661-71.
57. Havelock JC, Keller P, Muleba N, et al. Human myometrial gene expression before and during parturition. Biol Reprod 2005;72: 707-19.
58. Hassan SS, Romero R, Haddad R, et al. The transcriptome of the uterine cervix before and after spontaneous term parturition. Am J Obstet Gynecol 2006;195:778-86.
59. Bukowski R, Hankins GD, Saade GR, et al. Labor-associated gene expression in the human uterine fundus, lower segment, and cervix. PLoS Med 2006;3:e169.
60. Romero R, Tarca AL, Tromp G. Insights into the physiology of childbirth using transcriptomics. PLoS Med 2006;3:e276.
61. Hassan SS, Romero R, Tarca AL, et al. Signature pathways identified from gene expression profiles in the human uterine cervix before and after spontaneous term parturition. Am J Obstet Gynecol 2007;197:250.e251-7.
62. O'Brien M, Morrison JJ, Smith TJ. Upregulation of PSCDBP, TLR2, TWIST1, FLJ35382, EDNRB, and RGS12 gene expression in human myometrium at labor. Reprod Sci 2008;15: 382-93.
63. Hassan SS, Romero R, Tarca AL, et al. The transcriptome of cervical ripening in human pregnancy before the onset of labor at term: identification of novel molecular functions involved in this process. J Matern Fetal Neonatal Med 2009; 22:1183-93.
64. Mittal P, Romero R, Tarca AL, et al. Characterization of the myometrial transcriptome and biological pathways of spontaneous human labor at term. J Perinat Med 2010;38:617-43.
65. Nhan-Chang CL, Romero R, Tarca AL, et al. Characterization of the transcriptome of chorioamniotic membranes at the site of rupture in spontaneous labor at term. Am J Obstet Gynecol 2010; 202:462.e1-41.
66. Hassan SS, Romero R, Tarca AL, et al. The molecular basis for sonographic cervical shortening at term: identification of differentially expressed genes and the epithelial-mesenchymal transition as a function of cervical length. Am J Obstet Gynecol 2010;203: 472.e1-14.
67. Mittal P, Romero R, Tarca AL, et al. A molecular signature of an arrest of descent in human parturition. Am J Obstet Gynecol 2011; 204:177.e115-33.
68. Mosher AA, Rainey KJ, Giembycz MA, et al. Prostaglandin E2 represses interleukin 1 beta-induced inflammatory mediator output from pregnant human myometrial cells through the EP2 and EP4 receptors. Biol Reprod 2012;87:7 (1-10).
69. Lim S, MacIntyre DA, Lee YS, et al. Nuclear factor kappa B activation occurs in the amnion prior to labour onset and modulates the expression of numerous labour associated genes. PLoS One 2012;7:e34707.
70. Chaemsaithong P, Madan I, Romero R, et al. Characterization of the myometrial transcriptome in women with an arrest of dilatation during labor. J Perinat Med 2013;41:665-81.
71. Mattick JS, Makunin IV. Non-coding RNA. Hum Mol Genet 2006; 15:R17-29.
72. Mattick JS. The genetic signatures of noncoding RNAs. PLoS Genet 2009;5:e1000459.
73. Jia H, Osak M, Bogu GK, et al. Genome-wide computational identification and manual annotation of human long noncoding RNA genes. RNA 2010;16:1478-87.
74. Lipovich L, Johnson R, Lin CY. MacroRNA underdogs in a microRNA world: evolutionary, regulatory, and biomedical significance of mammalian long non-protein-coding RNA. Biochim Biophys Acta 2010;1799:597-615.
75. Cabili MN, Trapnell C, Goff L, et al. Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev 2011;25:1915-27.
76. Clark MB, Mattick JS. Long noncoding RNAs in cell biology. Semin Cell Dev Biol 2011;22:366-76.
77. Wang KC, Chang HY. Molecular mechanisms of long noncoding RNAs. Mol Cell 2011;43:904-14.
78. Derrien T, Johnson R, Bussotti G, et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res 2012;22: 1775-89.
79. Rinn JL, Chang HY. Genome regulation by long noncoding RNAs. Annu Rev Biochem 2012;81:145-66.
80. Hacisuleyman E, Cabili MN, Rinn JL. A Keystone for ncRNA. Genome Biol 2012;13:315.
81. Guttman M, Rinn JL. Modular regulatory principles of large non-coding RNAs. Nature 2012;482:339-46.
82. Gutschner T, Diederichs S. The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol 2012;9:703-19.
83. Kung JT, Colognori D, Lee JT. Long noncoding RNAs: past, present, and future. Genetics 2013;193:651-69.
84. Mercer TR, Mattick JS. Structure and function of long noncoding RNAs in epigenetic regulation. Nat Struct Mol Biol 2013;20: 300-7.
85. Batista PJ, Chang HY. Long noncoding RNAs: cellular address codes in development and disease. Cell 2013;152:1298-307.
86. Pacora P, Chaiworapongsa T, Maymon E, et al. Funisitis and chorionic vasculitis: the histological counterpart of the fetal inflammatory response syndrome. J Matern Fetal Neonatal Med 2002;11:18-25.
87. Redline RW. Inflammatory responses in the placenta and umbilical cord. Semin Fetal Neonatal Med 2006;11:296-301.
88. Gibbs RS, Castillo MS, Rodgers PJ. Management of acute chorioamnionitis. Am J Obstet Gynecol 1980;136:709-13.
89. Alexander GR, Himes JH, Kaufman RB, et al. A United States national reference for fetal growth. Obstet Gynecol 1996;87: 163-8.
90. Harrow J, Frankish A, Gonzalez JM, et al. GENCODE: the reference human genome annotation for The ENCODE Project. Genome Res 2012;22:1760-74.
91. Grinchuk OV, Jenjaroenpun P, Orlov YL, et al. Integrative analysis of the human cis-antisense gene pairs, miRNAs and their transcription regulation patterns. Nucleic Acids Res 2010;38: 534-47.
92. Wood E, Chin-Inmanu K, Jia H, Lipovich L. Sense-antisense gene pairs: sequence, transcription, and structure are not conserved between human and mouse. Frontiers Genetics 2013;4:183. doi: 10.3389/fgene.2013.00183.
93. UCSC Genome Bioinformatics. Available from: http://genome. ucsc.edu/. [last accessed Oct 2013].
94. The GENCODE Project: Encyclopædia of genes and gene variants. Available from: www.gencodegenes.org [last accessed Oct 2013].
95. Carninci P, Kasukawa T, Katayama S, et al. The transcriptional landscape of the mammalian genome. Science 2005;309:1559-63.
96. Kent WJ, Sugnet CW, Furey TS, et al. The human genome browser at UCSC. Genome Res 2002;12:996-1006.
97. Kent WJ. BLAT-the BLAST-like alignment tool. Genome Res 2002;12:656-64.
98. Bolstad BM, Irizarry RA, Astrand M, Speed TP. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003;19:185-93.
99. Benjamini Y, Drai D, Elmer G, et al. Controlling the false discovery rate in behavior genetics research. Behav Brain Res 2001;125:279-84.
100. Lipovich L, Dachet F, Cai J, et al. Activity-dependent human brain coding/noncoding gene regulatory networks. Genetics 2012;192: 1133-48.
101. Johnsson P, Lipovich L, Grandér D, Morris KV. Evolutionary conservation of long noncoding RNAs; sequence, structure, function. Biochim Biophys Acta. 2013. In press: http://dx.doi.org/10.1016/j.bbagen.2013.10.035.
102. Taylor DD, Bohler HC, Gercel-Taylor C. Pregnancy-linked suppression of TcR signaling pathways by a circulating factor absent in recurrent spontaneous pregnancy loss (RPL). Mol Immunol 2006;43:1872-80.
103. Street ME, Viani I, Ziveri MA, et al. Impairment of insulin receptor signal transduction in placentas of intra-uterine growthrestricted newborns and its relationship with fetal growth. Eur J Endocrinol 2011;164:45-52.
104. Rath N, Wang Z, Lu MM, Morrisey EE. LMCD1/Dyxin is a novel transcriptional cofactor that restricts GATA6 function by inhibiting DNA binding. Mol Cell Biol 2005;25:8864-73.
105. Bian ZY, Huang H, Jiang H, et al. LIM and cysteine-rich domains 1 regulates cardiac hypertrophy by targeting calcineurin/nuclear factor of activated T cells signaling. Hypertension 2010;55: 257-63.
106. International Human Genome Sequencing Consortium. Finishing the euchromatic sequence of the human genome. Nature 2004; 431:931-45.
107. Bernstein BE, Birney E, Dunham I, et al. An integrated encyclopedia of DNA elements in the human genome. Nature 2012;489:57-74.
108. Kapranov P, Willingham AT, Gingeras TR. Genome-wide transcription and the implications for genomic organization. Nat Rev Genet 2007;8:413-23.
109. Comings DE. The structure and function of chromatin. Adv Hum Genet 1972;3:237-431.
110. Ohno S. So much "junk" DNA in our genome. In: Smith H, ed. Evolution of genetic systems. New York: Gordon & Breach; 1972:366-70.
111. Willingham AT, Gingeras TR. TUF love for "junk" DNA. Cell 2006;125:1215-20.
112. Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: insights into functions. Nat Rev Genet 2009;10:155-9.
113. Knowling S, Morris KV. Non-coding RNA and antisense RNA. Nature's trash or treasure? Biochimie 2011;93:1922-7.
114. Mattick JS. Long noncoding RNAs in cell and developmental biology. Semin Cell Dev Biol 2011;22:327.
115. Magistri M, Faghihi MA, St Laurent 3rd G, Wahlestedt C. Regulation of chromatin structure by long noncoding RNAs: focus on natural antisense transcripts. Trends Genet 2012;28: 389-96.
116. Sheik Mohamed J, Gaughwin PM, Lim B, et al. Conserved long noncoding RNAs transcriptionally regulated by Oct4 and Nanog modulate pluripotency in mouse embryonic stem cells. RNA 2010;16:324-37.
117. Amaral PP, Mattick JS. Noncoding RNA in development. Mamm Genome 2008;19:454-92.
118. Mercer TR, Dinger ME, Sunkin SM, et al. Specific expression of long noncoding RNAs in the mouse brain. Proc Natl Acad Sci USA 2008;105:716-21.
119. Ponting CP, Oliver PL, Reik W. Evolution and functions of long noncoding RNAs. Cell 2009;136:629-41.
120. Guttman M, Amit I, Garber M, et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature 2009;458:223-7.
121. Wilusz JE, Sunwoo H, Spector DL. Long noncoding RNAs: functional surprises from the RNA world. Genes Dev 2009;23: 1494-504.
122. Wapinski O, Chang HY. Long noncoding RNAs and human disease. Trends Cell Biol 2011;21:354-61.
123. Ng SY, Bogu GK, Soh BS, Stanton LW. The long noncoding RNA RMST interacts with SOX2 to regulate neurogenesis. Mol Cell 2013;51:349-59.
124. Johnsson P, Ackley A, Vidarsdottir L, et al. A pseudogene long-noncoding-RNA network regulates PTEN transcription and translation in human cells. Nat Struct Mol Biol 2013;20:440-6.
125. Faghihi MA, Modarresi F, Khalil AM, et al. Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase. Nat Med 2008;14: 723-30.
126. Xu B, Gerin I, Miao H, et al. Multiple roles for the non-coding RNA SRA in regulation of adipogenesis and insulin sensitivity. PLoS One 2010;5:e14199.
127. Moran I, Akerman I, van de Bunt M, et al. Human beta cell transcriptome analysis uncovers lncRNAs that are tissue-specific, dynamically regulated, and abnormally expressed in type 2 diabetes. Cell Metab 2012;16:435-48.
128. Sun L, Goff LA, Trapnell C, et al. Long noncoding RNAs regulate adipogenesis. Proc Natl Acad Sci USA 2013;110:3387-92.
129. Kim YM, Romero R, Chaiworapongsa T, et al. Toll-like receptor-2 and-4 in the chorioamniotic membranes in spontaneous labor at term and in preterm parturition that are associated with chorioamnionitis. Am J Obstet Gynecol 2004; 191:1346-55.
130. Haddad R, Tromp G, Kuivaniemi H, et al. Human spontaneous labor without histologic chorioamnionitis is characterized by an acute inflammation gene expression signature. Am J Obstet Gynecol 2006;195:394.e1-24.
131. Osman I, Young A, Ledingham MA, et al. Leukocyte density and pro-inflammatory cytokine expression in human fetal membranes, decidua, cervix and myometrium before and during labour at term. Mol Hum Reprod 2003;9:41-5.
132. Mittal P, Romero R, Mazaki-Tovi S, et al. Fetal membranes as an interface between inflammation and metabolism: increased aquaporin 9 expression in the presence of spontaneous labor at term and chorioamnionitis. J Matern Fetal Neonatal Med 2009;22: 1167-75.
133. Than NG, Romero R, Tarca AL, et al. Mitochondrial manganese superoxide dismutase mRNA expression in human chorioamniotic membranes and its association with labor, inflammation, and infection. J Matern Fetal Neonatal Med 2009;22:1000-13.
134. Bollapragada S, Youssef R, Jordan F, et al. Term labor is associated with a core inflammatory response in human fetal membranes, myometrium, and cervix. Am J Obstet Gynecol 2009; 200:104.e101-11.
135. Hertelendy F, Romero R, Molnar M, et al. Cytokine-initiated signal transduction in human myometrial cells. Am J Reprod Immunol 1993;30:49-57.
136. Belt AR, Baldassare JJ, Molnar M, et al. The nuclear transcription factor NF-kappaB mediates interleukin-1beta-induced expression of cyclooxygenase-2 in human myometrial cells. Am J Obstet Gynecol 1999;181:359-66.
137. Molnar M, Rigo Jr J, Romero R, Hertelendy F. Oxytocin activates mitogen-activated protein kinase and up-regulates cyclooxygenase-2 and prostaglandin production in human myometrial cells. Am J Obstet Gynecol 1999;181:42-9.
138. Allport VC, Pieber D, Slater DM, et al. Human labour is associated with nuclear factor-kappaB activity which mediates cyclo-oxygenase-2 expression and is involved with the 'functional progesterone withdrawal'. Mol Hum Reprod 2001;7: 581-6.
139. Jenkin G, Young IR. Mechanisms responsible for parturition; the use of experimental models. Anim Reprod Sci 2004;82-83: 567-81.
140. Rizzo A, Roscino MT, Binetti F, Sciorsci RL. Roles of reactive oxygen species in female reproduction. Reprod Domest Anim 2012;47:344-52.
141. Liggins G. Cervical ripening as an inflamamtory reaction. In: Ellwood D, Anderson A, eds. The cervix in pregnancy and labor: clinical and biochemical investigations. Edinburgh: Churchill Livingstone; 1981:1-9.
142. Sennstrom MB, Ekman G, Westergren-Thorsson G, et al. Human cervical ripening, an inflammatory process mediated by cytokines. Mol Hum Reprod 2000;6:375-81.
143. Kelly RW. Inflammatory mediators and cervical ripening. J Reprod Immunol 2002;57:217-24.
144. Stjernholm-Vladic Y, Stygar D, Mansson C, et al. Factors involved in the inflammatory events of cervical ripening in humans. Reprod Biol Endocrinol 2004;2:74.
145. Dubicke A, Fransson E, Centini G, et al. Pro-inflammatory and anti-inflammatory cytokines in human preterm and term cervical ripening. J Reprod Immunol 2010;84:176-85.
146. Romero R, Parvizi ST, Oyarzun E, et al. Amniotic fluid interleukin-1 in spontaneous labor at term. J Reprod Med 1990; 35:235-8.
147. Romero R, Ceska M, Avila C, et al. Neutrophil attractant/activating peptide-1/interleukin-8 in term and preterm parturition. Am J Obstet Gynecol 1991;165:813-20.
148. Romero R, Mazor M, Brandt F, et al. Interleukin-1 alpha and interleukin-1 beta in preterm and term human parturition. Am J Reprod Immunol 1992;27:117-23.
149. Cox SM, King MR, Casey ML, MacDonald PC. Interleukin-1 beta,-1 alpha, and-6 and prostaglandins in vaginal/cervical fluids of pregnant women before and during labor. J Clin Endocrinol Metab 1993;77:805-15.
150. Saito S, Kasahara T, Kato Y, et al. Elevation of amniotic fluid interleukin 6 (IL-6), IL-8 and granulocyte colony stimulating factor (G-CSF) in term and preterm parturition. Cytokine 1993;5:81-8.
151. Austgulen R, Lien E, Liabakk NB, et al. Increased levels of cytokines and cytokine activity modifiers in normal pregnancy. Eur J Obstet Gynecol Reprod Biol 1994;57:149-55.
152. Osmers RG, Blaser J, Kuhn W, Tschesche H. Interleukin-8 synthesis and the onset of labor. Obstet Gynecol 1995;86:223-9.
153. Steinborn A, Kuhnert M, Halberstadt E. Immunmodulating cytokines induce term and preterm parturition. J Perinat Med 1996;24:381-90.
154. Tanaka Y, Narahara H, Takai N, et al. Interleukin-1beta and interleukin-8 in cervicovaginal fluid during pregnancy. Am J Obstet Gynecol 1998;179:644-9.
155. Athayde N, Romero R, Maymon E, et al. A role for the novel cytokine RANTES in pregnancy and parturition. Am J Obstet Gynecol 1999;181:989-94.
156. Keelan JA, Marvin KW, Sato TA, et al. Cytokine abundance in placental tissues: evidence of inflammatory activation in gestational membranes with term and preterm parturition. Am J Obstet Gynecol 1999;181:1530-6.
157. Challis JRG, Matthews SG, Gibb W, Lye SJ. Endocrine and paracrine regulation of birth at term and preterm. Endocr Rev 2000;21:514-50.
158. Esplin MS, Romero R, Chaiworapongsa T, et al. Amniotic fluid levels of immunoreactive monocyte chemotactic protein-1 increase during term parturition. J Matern Fetal Neonatal Med 2003;14:51-6.
159. Gotsch F, Romero R, Kusanovic JP, et al. The anti-inflammatory limb of the immune response in preterm labor, intra-amniotic infection/inflammation, and spontaneous parturition at term: a role for interleukin-10. J Matern Fetal Neonatal Med 2008;21: 529-47.
160. Hamill N, Romero R, Gotsch F, et al. Exodus-1 (CCL20): evidence for the participation of this chemokine in spontaneous labor at term, preterm labor, and intrauterine infection. J Perinat Med 2008;36:217-27.
161. Bogavac MA, Brkic S. Serum proinflammatory cytokine-interleukin-8 as possible infection site marker in preterm deliveries. J Perinat Med 2009;37:707-8.
162. Nace J, Fortunato SJ, Maul H, Menon R. The expression pattern of two novel cytokines (IL-24 and IL-29) in human fetal membranes. J Perinat Med 2010;38:665-70.
163. Hua R, Pease JE, Sooranna SR, et al. Stretch and inflammatory cytokines drive myometrial chemokine expression via NF-kappaB activation. Endocrinology 2012;153:481-91.
164. Hua R, Pease JE, Cheng W, et al. Human labour is associated with a decline in myometrial chemokine receptor expression: the role of prostaglandins, oxytocin and cytokines. Am J Reprod Immunol 2013;69:21-32.
165. Mitchell MD, Edwin S, Romero RJ. Prostaglandin biosynthesis by human decidual cells: effects of inflammatory mediators. Prostaglandins Leukot Essent Fatty Acids 1990;41:35-8.
166. Dowling DD, Romero RJ, Mitchell MD, Lundin-Schiller S. Isolation of multiple substances in amniotic fluid that regulate amnion prostaglandin E2 production: the effects of gestational age and labor. Prostaglandins Leukot Essent Fatty Acids 1991;44: 253-5.
167. Romero R, Gonzalez R, Baumann P, et al. Topographic differences in amniotic fluid concentrations of prostanoids in women in spontaneous labor at term. Prostaglandins Leukot Essent Fatty Acids 1994;50:97-104.
168. Romero R, Baumann P, Gonzalez R, et al. Amniotic fluid prostanoid concentrations increase early during the course of spontaneous labor at term. Am J Obstet Gynecol 1994;171: 1613-20.
169. Mitchell MD, Romero RJ, Edwin SS, Trautman MS. Prostaglandins and parturition. Reprod Fertil Dev 1995;7: 623-32.
170. Edwin SS, Romero RJ, Munoz H, et al. 5-Hydroxyeicosatetraenoic acid and human parturition. Prostaglandins 1996;51:403-12.
171. Romero R, Munoz H, Gomez R, et al. Increase in prostaglandin bioavailability precedes the onset of human parturition. Prostaglandins Leukot Essent Fatty Acids 1996;54:187-91.
172. Gibb W. The role of prostaglandins in human parturition. Ann Med 1998;30:235-41.
173. Keelan JA, Sato TA, Gupta DK, et al. Prostanoid stimulation of cytokine production in an amnion-derived cell line: evidence of a feed-forward mechanism with implications for term and preterm labor. J Soc Gynecol Investig 2000;7:37-44.
174. Mitchell MD, Chang MC, Chaiworapongsa T, et al. Identification of 9alpha,11beta-prostaglandin F2 in human amniotic fluid and characterization of its production by human gestational tissues. J Clin Endocrinol Metab 2005;90:4244-8.
175. Lee SE, Romero R, Park IS, et al. Amniotic fluid prostaglandin concentrations increase before the onset of spontaneous labor at term. J Matern Fetal Neonatal Med 2008;21:89-94.
176. Romero R, Emamian M, Wan M, et al. Increased concentrations of arachidonic acid lipoxygenase metabolites in amniotic fluid during parturition. Obstet Gynecol 1987;70:849-51.
177. Romero R, Wu YK, Mazor M, et al. Increased amniotic fluid leukotriene C4 concentration in term human parturition. Am J Obstet Gynecol 1988;159:655-7.
178. Romero R, Wu YK, Mazor M, et al. Amniotic fluid concentration of 5-hydroxyeicosatetraenoic acid is increased in human parturition at term. Prostaglandins Leukot Essent Fatty Acids 1989;35: 81-3.
179. Blumenstein M, Bowen-Shauver JM, Keelan JA, Mitchell MD. Identification of suppressors of cytokine signaling (SOCS) proteins in human gestational tissues: differential regulation is associated with the onset of labor. J Clin Endocrinol Metab 2002; 87:1094-7.
180. Katayama S, Tomaru Y, Kasukawa T, et al. Antisense transcription in the mammalian transcriptome. Science 2005; 309:1564-6.
181. Lee JT, Bartolomei MS. X-inactivation, imprinting, and long noncoding RNAs in health and disease. Cell 2013;152:1308-23.
182. Martianov I, Ramadass A, Serra Barros A, et al. Repression of the human dihydrofolate reductase gene by a non-coding interfering transcript. Nature 2007;445:666-70.
183. Almada AE, Wu X, Kriz AJ, et al. Promoter directionality is controlled by U1 snRNP and polyadenylation signals. Nature 2013;499:360-3.
184. van Dijk M, Thulluru HK, Mulders J, et al. HELLP babies link a novel lincRNA to the trophoblast cell cycle. J Clin Invest 2012; 122:4003-11.
185. van Dijk M, Oudejans C. (Epi)genetics of pregnancy-associated diseases. Front Genet 2013;4:180.-baba ^^Perinatology Research Branch-baba ^^Division of Intramural Research-baba ^^Eunice Kennedy Shriver National Institute of Child Health and Human Development-baba ^NIH^National Institutes of Health-baba ^^Department of Health and Human Services-baba-info This research was supported, in part, by the Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services (NICHD/NIH); and, in part, with Federal funds from NICHD, NIH under Contract No. HHSN275201300006C. L.L. is a member of the ENCODE Consortium; however, no funds or material resources from ENCODE were used in this study.